Bioequivalence of the Test Formulation Clinical Trial
A Randomised, Single-dose, 4-way Crossover, Open-label, Pharmacokinetic Study Comparing a 4% (w/v) Suspension of Ibuprofen With a Reference 2% (w/v) Suspension of Ibuprofen in the Fed and Fasted States.
Bioequivalence evaluation of Nurofen for Children® with reference formulation of Algifor® Junior by determining and comparing the rate and extent of absorption in both fed and fasted states
|Source||Reckitt Benckiser Healthcare (UK) Limited|
|Start date||February 29, 2016|
|Completion date||May 6, 2016|